[Wobe-Mugos: a proteolytic enzyme combination for tumor therapy. Documentation No. 7].
D000818:Animals; D002918:Chymotrypsin; D004338:Drug Combinations / Q000627:therapeutic use; D004335:Drug and Narcotic Control; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000628:therapy; D010184:Pancreatic Extracts / Q000627:therapeutic use*; D010206:Papain / Q000627:therapeutic use*; D010447:Peptide Hydrolases / Q000009:adverse effects / Q000627:therapeutic use*; D013557:Switzerland; D013949:Thymus Extracts / Q000627:therapeutic use*; D014020:Tissue Extracts / Q000009:adverse effects / Q000627:therapeutic use*; D014357:Trypsin
D004338:Drug Combinations; D010184:Pancreatic Extracts; D013949:Thymus Extracts; D014020:Tissue Extracts; C009685:chymotrypsin, papain, trypsin drug combination; D010447:Peptide Hydrolases; D002918:Chymotrypsin; D014357:Trypsin; D010206:Papain
Wobe-Mugos: Proteolytische Enzymkombination für die Tumortherapie. Dokumentation Nr. 7.